Published in J Microencapsul on May 01, 2010
Nonionic surfactant vesicles for delivery of RNAi therapeutics. Nanomedicine (Lond) (2013) 0.80
Sodium dodecyl sulfate/β-cyclodextrin vesicles embedded in chitosan gel for insulin delivery with pH-selective release. Acta Pharm Sin B (2016) 0.75
Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol (2005) 2.76
Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol (2005) 2.61
Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe (2010) 2.49
Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol (2006) 2.40
Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infect Immun (2010) 2.33
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2007) 2.14
Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun (2006) 2.13
Activity of the major staphylococcal autolysin Atl. FEMS Microbiol Lett (2006) 2.06
Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J Infect Dis (2002) 2.05
Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J Biol Chem (2005) 2.00
De Novo Arteriovenous Malformation Growth Secondary to Implantation of Genetically Modified Allogeneic Mesenchymal Stem Cells in the Brain. Neurosurgery (2016) 1.96
Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog (2007) 1.92
Role of staphylococcal wall teichoic acid in targeting the major autolysin Atl. Mol Microbiol (2010) 1.82
Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection. Infect Immun (2005) 1.80
Comparative proteome analysis of Staphylococcus aureus biofilm and planktonic cells and correlation with transcriptome profiling. Proteomics (2006) 1.79
Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect Immun (2005) 1.76
Bacteria-derived peptidoglycans constitute pathogen-associated molecular patterns triggering innate immunity in Arabidopsis. J Biol Chem (2007) 1.68
Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer? Microbiology (2005) 1.68
Arabidopsis lysin-motif proteins LYM1 LYM3 CERK1 mediate bacterial peptidoglycan sensing and immunity to bacterial infection. Proc Natl Acad Sci U S A (2011) 1.65
Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA-binding properties of IcaR. Mol Microbiol (2003) 1.61
Bacterial evasion of innate host defenses--the Staphylococcus aureus lesson. Int J Med Microbiol (2004) 1.57
Inhibition of staphylococcal biofilm formation by nitrite. J Bacteriol (2007) 1.51
The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses. BMC Microbiol (2008) 1.51
Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J Bacteriol (2006) 1.50
Solitary spinal artery aneurysms as a rare source of spinal subarachnoid hemorrhage: potential etiology and treatment strategy. AJNR Am J Neuroradiol (2005) 1.43
The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect Immun (2006) 1.41
Genome analysis of the meat starter culture bacterium Staphylococcus carnosus TM300. Appl Environ Microbiol (2008) 1.38
A Staphylococcus aureus ypfP mutant with strongly reduced lipoteichoic acid (LTA) content: LTA governs bacterial surface properties and autolysin activity. Mol Microbiol (2007) 1.34
Microevolution of cytochrome bd oxidase in Staphylococci and its implication in resistance to respiratory toxins released by Pseudomonas. J Bacteriol (2006) 1.33
Suicidal erythrocyte death in sepsis. J Mol Med (Berl) (2006) 1.30
Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int J Med Microbiol (2008) 1.29
Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J Infect Dis (2008) 1.28
Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol (2010) 1.26
Lack of biofilm contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis. FEMS Immunol Med Microbiol (2003) 1.21
Structural basis of cell wall cleavage by a staphylococcal autolysin. PLoS Pathog (2010) 1.20
Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J (2010) 1.19
Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and iron-dependent growth in vivo. J Immunol (2009) 1.18
Marker removal in staphylococci via Cre recombinase and different lox sites. Appl Environ Microbiol (2007) 1.18
The ability of biofilm formation does not influence virulence of Staphylococcus aureus and host response in a mouse tissue cage infection model. Microb Pathog (2004) 1.18
Small-colony variant selection as a survival strategy for Staphylococcus aureus in the presence of Pseudomonas aeruginosa. Appl Environ Microbiol (2009) 1.16
Characterization of toxin production of coagulase-negative staphylococci isolated from food and starter cultures. Int J Food Microbiol (2008) 1.15
Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes. PLoS One (2010) 1.14
Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains. J Bacteriol (2009) 1.13
Phage release from biofilm and planktonic Staphylococcus aureus cells. FEMS Microbiol Lett (2005) 1.11
A novel staphylococcal internalization mechanism involves the major autolysin Atl and heat shock cognate protein Hsc70 as host cell receptor. Cell Microbiol (2010) 1.11
Advantage of upregulation of succinate dehydrogenase in Staphylococcus aureus biofilms. J Bacteriol (2010) 1.10
Staphylococcal major autolysin (Atl) is involved in excretion of cytoplasmic proteins. J Biol Chem (2010) 1.06
Characterization of the oxygen-responsive NreABC regulon of Staphylococcus aureus. J Bacteriol (2008) 1.05
Role of the twin-arginine translocation pathway in Staphylococcus. J Bacteriol (2009) 1.04
Ligand-binding properties and conformational dynamics of autolysin repeat domains in staphylococcal cell wall recognition. J Bacteriol (2012) 1.03
Proton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity. PLoS One (2012) 1.01
Pyruvate formate lyase acts as a formate supplier for metabolic processes during anaerobiosis in Staphylococcus aureus. J Bacteriol (2010) 0.98
Biological activities of phenolic compounds isolated from galls of Terminalia chebula Retz. (Combretaceae). Nat Prod Res (2010) 0.98
Anti-inflammatory and chemopreventive effects of triterpene cinnamates and acetates from shea fat. J Oleo Sci (2010) 0.97
Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother (2012) 0.96
Staphylococcal NreB: an O(2)-sensing histidine protein kinase with an O(2)-labile iron-sulphur cluster of the FNR type. Mol Microbiol (2004) 0.96
Biological activities of phenolic compounds and triterpenoids from the galls of Terminalia chebula. Chem Biodivers (2013) 0.96
What distinguishes highly pathogenic staphylococci from medium- and non-pathogenic? Curr Top Microbiol Immunol (2013) 0.94
The two-component signal transduction system ArlRS regulates Staphylococcus epidermidis biofilm formation in an ica-dependent manner. PLoS One (2012) 0.93
Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm (2010) 0.93
Human chitotriosidase is expressed in the eye and lacrimal gland and has an antimicrobial spectrum different from lysozyme. Microbes Infect (2007) 0.92
Characterization and comparison of 2 distinct epidemic community-associated methicillin-resistant Staphylococcus aureus clones of ST59 lineage. PLoS One (2013) 0.92
Artifacts caused by cochlear implants with non-removable magnets in 3T MRI: phantom and cadaveric studies. Eur Arch Otorhinolaryngol (2009) 0.91
Transcriptomic and metabolic responses of Staphylococcus aureus exposed to supra-physiological temperatures. BMC Microbiol (2009) 0.91
Nonribosomal synthesis of fengycin on an enzyme complex formed by fengycin synthetases. J Biol Chem (2006) 0.91
In vitro and in vivo skin anti-aging evaluation of gel containing niosomes loaded with a semi-purified fraction containing gallic acid from Terminalia chebula galls. Pharm Biol (2011) 0.91
WIPI-1 Positive Autophagosome-Like Vesicles Entrap Pathogenic Staphylococcus aureus for Lysosomal Degradation. Int J Cell Biol (2012) 0.90
Impact of coexpression and coamplification of sICAM and antiapoptosis determinants bcl-2/bcl-x(L) on productivity, cell survival, and mitochondria number in CHO-DG44 grown in suspension and serum-free media. Biotechnol Bioeng (2002) 0.90
The phage lytic proteins from the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistance. PLoS One (2013) 0.90
Treatment of mandibular high-flow vascular malformations: report of 2 cases. J Oral Maxillofac Surg (2011) 0.90
Phylogeny of the staphylococcal major autolysin and its use in genus and species typing. J Bacteriol (2012) 0.89
Muropeptide modification-amidation of peptidoglycan D-glutamate does not affect the proinflammatory activity of Staphylococcus aureus. Infect Immun (2007) 0.89
Enhancement of androstadienedione production from progesterone by biotransformation using the hydroxypropyl-beta-cyclodextrin complexation technique. J Steroid Biochem Mol Biol (2007) 0.88
Impact of Staphylococcus aureus on pathogenesis in polymicrobial infections. Infect Immun (2014) 0.88
Staphylococcal lipoproteins and their role in bacterial survival in mice. Int J Med Microbiol (2009) 0.88
A new class of quorum quenching molecules from Staphylococcus species affects communication and growth of gram-negative bacteria. PLoS Pathog (2013) 0.88
Pathogen-triggered activation of plasmacytoid dendritic cells induces IL-10-producing B cells in response to Staphylococcus aureus. J Immunol (2013) 0.87
In vitro anti-aging activities of Terminalia chebula gall extract. Pharm Biol (2010) 0.86
Triggering of dendritic cell apoptosis by xanthohumol. Mol Nutr Food Res (2010) 0.86
The tape measure protein of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA35 has an active muramidase domain. Appl Environ Microbiol (2012) 0.86
Cell wall antibiotics provoke accumulation of anchored mCherry in the cross wall of Staphylococcus aureus. PLoS One (2012) 0.85
Synthesis of a novel fluorescent ceramide analogue and its use in the characterization of recombinant ceramidase from Pseudomonas aeruginosa PA01. Chem Phys Lipids (2002) 0.85
Genomic differences between the food-grade Staphylococcus carnosus and pathogenic staphylococcal species. Int J Med Microbiol (2009) 0.85
Chemical stability and cytotoxicity of human insulin loaded in cationic DPPC/CTA/DDAB liposomes. J Biomed Nanotechnol (2011) 0.85
Anti-aging efficacy of topical formulations containing niosomes entrapped with rice bran bioactive compounds. Pharm Biol (2012) 0.85
Quantitative MRI shows cerebral microstructural damage in hemolytic-uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI. Neuroradiology (2013) 0.85
Understanding the physiology and adaptation of staphylococci: a post-genomic approach. Int J Med Microbiol (2007) 0.84
User configurable microfluidic device for multiplexed immunoassays based on DNA-directed assembly. Anal Chem (2009) 0.83
Anticancer activities of the extract from Longkong (Lansium domesticum) young fruits. Pharm Biol (2012) 0.83
Microsurgical clipping of previously coiled intracranial aneurysms. Clin Neurol Neurosurg (2013) 0.83